All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-MYD88 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-2531-FY | 2E9C2 | Mouse | Human | IgG2b | Recombinant protein corresponding to amino acids 176 to 280 of human MyD88 | |
DMAb-2532-FY | CBFYM-0092 | Mouse | Human | IgG2b, k | Recombinant human MYD88 (1-309aa) purified from E. coli | |
DMAb-2533-FY | CBFYM-0124 | Rat | Human | IgG2a | E. coli-derived recombinant human MyD88, Met1-Pro296 | |
DMAb-2534-FY | CBFYM-0164 | Mouse | Human | IgG1, k | Synthetic peptide (68 DFEYLEIRQLETQADPTGR 86) of MyD88 protein | |
DMAb-2535-FY | CBFYM-2899 | Mouse | Human | IgG2b | Recombinant protein corresponding to aa176-280 from human MyD88 | |
DMAb-2536-FY | CBFYM-2900 | Mouse | Human | IgG2a | MYD88 antibody was raised in mouse using a full length recombinant protein of human MYD88 (NP_002459) produced in HEK293T cells, | |
DMAb-2537-FY | CBFYM-2901 | Mouse | Human | Recombinant protein corresponding to aa1-309 from human MYD88 expressed in E. coli | ||
DMAb-2538-FY | CBFYM-2902 | Mouse | Human | IgG2b | ||
DMAb-2539-FY | CBFYM-2903 | Mouse | Human | IgG1 | ||
DMAb-2540-FY | CBFYM-2904 | Rabbit | Human | IgG | Synthetic peptide corresponding to residues surrounding Cys233 of human MyD88 protein | |
DMAb-2541-FY | CBFYM-2905 | Mouse | Rat |
There are currently no customer reviews or questions for Anti-MYD88 DNA-encoded mAb (DMAb), pVAX1 (DMAb-2531-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION